Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION(R) System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...
Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION® System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...
Reports Q3 revenue $388,000 vs. $33,000 last year. “As demonstrated by our revenue growth, reduced cost structure and improved bottom line in ...
Third quarter 2025 revenue grew more than tenfold year-over-year and 30% sequentially quarter-over-quarter, demonstrating ...
The human visual system provides us with a rich and meaningful percept of the world, transforming retinal signals into visuo-semantic representations. For a model of these representations, here we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results